Smith E, Rothschild AJ, Heo M, Peasley-Miklus C, Caswell M, Papademetriou E, Flint AJ, Mulsant BH, Meyers BS; STOP-PD Collaborative Study Group. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol. 2008;23(3):130-137....
METHOD: Hospitalized patients with the discharge diagnosis of DSM-IV psychotic depression (major depression with psychotic features or bipolar I disorder, depressed phase...with psychotic features) who had been treated with olanzapine during the first 9 months of its availability in the United States ...
olanzapine 5 to 20 mg/day was significantly superior to haloperidol 5 to 20 mg/day in overall improvements in psychopathology rating scales and in the treatment of depressive and negative symptoms, and was comparable in effects on positive psychotic symptoms. The 1-year risk of relapse (rehospita...
The recommended treatment for resistantdepressionis 5-20 mg of olanzapine combined with 20-50 mg of fluoxetine once daily in the evening while the recommended treatment for depressionassociated with bipolar disorder is 5-12.5 mg olanzapine combined with 20-50 mg fluoxetine once daily in the evening...
Olanzapine, mean dose 5.4mg/day, has been given to 21 patients with apathy in theabsenceof depression after long-term treatment withselective serotonin reuptake inhibitorsfor non-psychotic depression in an open, flexible-dose study [16]. The more frequentadverse effectswere sedation (n=12), incre...
Examines the case of a 54-year-old woman with probable Alzheimer's disease who developed myoclonic status during treatment with olanzapine for psychotic episodes. Dosage of olanzapine given to the woman; Results of ECG; Reason that the antipsychotic was judged responsible for the myoclonic status....
The man started receiving olanzapine 20 mg/day for management of an acute polymorphic psychotic episode. Postpsychotic depression developed 5 months later, and duloxetine 60 mg/day was added to his olanzapine therapy; at this time, his olanzapine serum concentration was 22 g/L and his prolactin ...
moderately severe depression with comorbidsubstance abuse; (v) moderate to severe depression with physicaldisorders; (vi) severe depression with melancholia; (vii) recurrentdepression or failure to respond to a preferred first-line treatment;and (viii) psychotic depression, and severe depression with ri...
Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study There are conflicting results on the impact of anxiety on depression outcomes. The impact of anxiety has not been studied in major depression with psychoti... SJC Davies...
combination with antidepressants for treatment-resistant nonpsychotic depression (TRD) or major depressive disorder (MDD) inadequately responsive to antidepressants... SL Mcelroy,A Guerdjikova,N Mori,... - 《Expert Opinion on Investigational Drugs》 被引量: 28发表: 2010年 加载更多来源...